Vivek Shah
Analyst · JPMorgan. Cory your line is live
Thank you, Scott, and good morning, everyone. We save the best for last, reporting record breaking revenues, adjusted EBITDA and adjusted EPS for Q4 2020. Since the onset of the pandemic, we have strung together exceptional results, which speak to how resilient, focused and creative our organization has been. I could hardly be prouder of our employees around the world and want to express my immense gratitude for their remarkable efforts. Our performance is also indicative of the quality of our diversified portfolio of digital brands, which we continue to believe are very well-positioned for a post-pandemic world. The Digital Media segment had an outstanding quarter, with revenues up 26% year-over-year. We saw strong growth and positive signs at a number of our businesses. In our Gaming business, IGN had a very strong quarter, as the start of the new console cycle unlocked budgets, as we hoped. We view advertising in the Gaming and Streaming Service categories as a nice tailwind going into 2021. At Humble Bundle, we launched 35 skews in 2020, more than doubled last year. Given our continued success in indie game publishing, we were planning to invest in building out our Humble Games team to accelerate the number of titles we launched in the future. Our broadband assets had their best quarter of the year. Ookla set another record, with 1.8 billion tests in the quarter. And in a stat that I find stunning, Ookla’s mobile app installs topped 500 million. Ekahau, which as you’ll recall, saw its revenues dip in Q2, when WiFi planning work being done in commercial spaces came to a halt, had a strong finish to the year. With particularly robust growth in Asia, which we believe indicates we could see growth acceleration in the U.S. when COVID is better contained. A brand that has emerged with a strong consumer use case is DownDetector, which saw its visits grow 45% year-over-year and is now the go-to site for consumers to report and view website, and app outages. We’ve had some good success monetizing the asset to the launch of DownDetector Enterprise, which provides service providers a real time monitoring dashboard and alert system. The early integration of RetailMeNot has exceeded our expectations. We saw good traction on total retail sales attributed to the platform and have done most of the foundational work for us to start deploying editorial and deal content, which is central to our efforts at growing commission rates. We did see a slight uptick in commission rates in Q4, which mostly had to do with favorable mix. Our margin expansion plan is progressing according to expectations and we internally announced a re-org a couple of weeks ago. As you know, one of the assets inside of RetailMeNot that we’re very bullish about is the Deal Finder browser app, which competes with Honey and others. In Q4 installs grew 160% and our merchant coverage grew 16%, both of which are key drivers of revenue. Given the momentum, we’re also increasing our investments in generating installs and accelerating merchant on-boarding for Deal Finder. The Everyday Health Group continues to realize the benefit of the shift to pharma marketing, away from traditional methods of reaching patients and doctors to digital vehicles. The pandemic simply accelerated what was already a trend. Our help sites continue to see strong traffic and are being recognized in the industry for their trusted content. everydayhealth.com won 13 digital health awards honoring the world’s best digital health resources and PRIME Education won the William Campbell Felch Award, the most prestigious award in the continuing medical education industry. We’ve also dedicated significant editorial resources focused on mental health and racial disparities in healthcare and health outcomes. We welcome Dr. Patrice Harris to Everyday Health as its Medical Editor in Chief. Dr. Harris is the immediate past President of the American Medical Association, the AMA, and a world renowned psychiatrist. BabyCenter celebrated its first year of ownership inside of the Everyday Health Group, and I must say, that it was amongst the smoothest and most successful integrations we’ve had. Our pregnancy and parenting platform has an unsurpassed reach of expecting parents and we are proud to have been selected to be a clinical trial recruitment partner for one of the COVID-19 vaccine suppliers to help them understand the impact of the vaccine on pregnant women and young children. The Cloud Services segment grew over 3% in Q4, when adjusting for previously disposed assets. With our Cloud Fax business having looked can only be characterized as a breakout quarter. Total Cloud Fax revenues grew over 6% and the corporate part of the business grew nearly 17%. This cap was easily the best year for Cloud Fax in the eight years that I’ve been at the company. It’s a direct result of the investments and focus we’ve made in ensuring strong service delivery, pushing new product features and expanding capacity. Page volumes have fully recovered from their lows in Q2 and were up 22% year over year. Our core cybersecurity suite of endpoint, email and VPN had another nice growth quarter, and we’re beginning to see the benefits of these businesses being organized under a single leader. As we evolve our approach to cybersecurity, and as we stated in our earnings release last night, our Board has approved the exploration of strategic alternatives for our KeepItSafe, LiveVault and ODS businesses, which do not factor in or bundling or cross-selling efforts or plans. While we see potential in the B2B backup business, it does not map to our areas of focus. We think the business may more fully reach its potential with a new owner, which is why we are exploring alternatives. I’ll also point out that over the past few years we’ve been consistently optimizing our portfolio. In fact, in our Voice business, we exited our Australia businesses last year and earlier this week, we sold our U.K.-based City Numbers and CallStream businesses. These businesses simply didn’t fit our strategy and weren’t in a position to compete for growth or acquisition capital at J2 and that competition gets stronger each year, as the caliber of organic and acquisition opportunities for many of our businesses continues to rise. For the full year, we generated adjusted EBITDA and EPS of $616 million and $8.18, respectively. What’s most remarkable is that the high end of our pre-COVID guidance was $595 million in adjusted EBITDA and $7.66 in EPS, we grew by the high end of the range for both. Alongside the great financial value creation in 2020, was the company’s tremendous social value creation. For those of you who participated in our ESG Non-Deal Roadshow last month, and by the way, we’d like to have another roadshow for those who couldn’t participate in the first one. You know that we’ve organized our purpose-driven agenda around five pillars, diversity, equity and inclusion, community, sustainability, data, and governance. We’ve made immense progress in all areas and we will continue to drive purpose just like we drive profits. We’ve also learned that we need to provide more disclosures to ensure that the ratings agencies have a fuller appreciation of our activities policies and approaches. Scott will take you through the build for 2021 guidance, but I wanted to make a few observations about our outlook. First, given the higher organic growth we experienced in the second half of 2020, we believe that the overall organic growth rate for J2 in 2021 will be closer to high-single digits with total growth in the mid teens. Given the organic growth opportunities, we’re increasing customer acquisition spending in a few areas, including cybersecurity, MarTech and RetailMeNot to support future growth. Not a huge investment, but it does probably cost us a point of margin in 2021. I also believe that every single business unit in the company will grow its revenues, which would make this the first year in a while that we do not have any of our businesses posting negative growth. The combination of removing our dilutive businesses, investing in growth opportunities and continuing our acquisitions program should have a meaningful impact on total top and bottomline growth. On the acquisitions front, we deployed approximately $500 million of capital in 2020, which exceeded 2019 spend of approximately $440 million. The pipeline is strong and we continue to see interesting opportunities for our capital. Our balance sheet continues to replenish with over $300 million of cash and we expect to continue to generate in excess of $400 million in annual free cash flow. We also believe we have room in our leverage ratio to take on more debt, if we so choose. Our powder is dry and the market is full of interesting opportunities. Before I hand the call back to Scott, I’d like to take a moment to remember Bob Cresci, who’s one of J2’s original and longest serving Board members. Bob passed away in December, leaving behind an amazing legacy of achievement and honor. Bob was a tremendous person who loved his family, his country and our company. He was a graduate of West Point, served two tours in Vietnam and earned a Purple Heart and Bronze Star. He was a terrific athlete, having Captain the West Point water polo team and developed into a great tennis player. He had a distinguished career as an investor and I’d like to thank that his investment in J2 over 20 years ago was amongst his favorites. Bob was a great source of advice, guidance and inspiration for me. He was also one of the best storytellers I knew and beamed with pride whenever those stories involved his family To his wife, Mary Beth, and the whole Cresci family, we’re terribly sorry for your loss. He’s truly missed by all of us at J2.